Bacterial Warfare: Toxins, mutations and adaptations

The toxins that some bacteria secrete to kill off rival species can also generate mutations that help toxin-resistant populations adapt to new environments.
  1. Maarten De Jong
  2. Neal M Alto  Is a corresponding author
  1. Department of Microbiology, University of Texas Southwestern Medical Center, United States

Bacterial communities are often comprised of numerous different species which either co-exist in harmony or compete with each other for resources. To gain an upper hand on the competition, some bacteria have developed a form of needle-like machinery called a type VI secretion system (or T6SS for short) that injects toxic proteins directly into their rivals (Basler et al., 2012; Hood et al., 2010; Klein et al., 2020; Russell et al., 2011). It is generally thought that the toxins secreted by T6SS decapacitate the target organism by impairing important processes such as cell wall synthesis, ATP production and DNA replication (Ahmad et al., 2019; Jurėnas and Journet, 2020; Whitney et al., 2015). While these toxins are clearly involved in anti-bacterial warfare, it is unclear whether T6SS can also facilitate symbiotic relationships within bacterial communities.

Recently, a collaboration between groups led by Joseph Mougous (University of Washington) and David Liu (Harvard University and the Broad Institute) discovered that the T6SS of Burkholderia cenocepacia secretes a toxin called DddA that catalyzes the removal of an amino group from cytosine, converting it to uracil (Mok et al., 2020). In most cells, these enzymes – known as cytosine deaminases – are important for maintaining the levels of nucleotide precursors in cells (Neuhard, 1968). While most cytosine deaminases catalyze this reaction in single-stranded DNA, DddA is the first enzyme found to convert cytosine to uracil in double-stranded DNA. However, uracil is normally only found in RNA, where it pairs with another nucleotide base called adenosine: in DNA, adenosine pairs with thymine, whereas cytosine pairs with guanine in both DNA and RNA (Figure 1).

The DddA toxin from B. cenocepacia affects other bacterial species in different ways.

DddA is a toxin that removes an amino group from cytosine (C; green), converting it into uracil (U; yellow) in chromosomal DNA (top). In some bacterial species uracil is then removed by the DNA repair machinery (left), which can lead to double-stranded DNA breaks and ultimately cell death. In bacteria resistant to the toxic effects of DddA, DNA breaks do not occur (right): instead, uracil is converted into thymine (T; orange), which causes guanine (G; red) to convert to adenosine (A; blue). This results in genetic variation within the targeted population, further diversifying the community of bacteria.

Now, in eLife, Mougous and colleagues – including Marcos de Moraes as first author – report that as well as destroying bacteria, DddA also provides a selective advantage for some bacteria in the community (de Moraes et al., 2021). The team (who are based at the University of Washington) found that when the bacterium B. cenocepacia injects DddA, uracil accumulates in the DNA of the targeted bacteria. Since uracil is normally only found in RNA, its presence triggers a repair mechanism that attempts to remove it from the DNA. However, this repair mechanism can lead to a break in one strand of the DNA, and if there are too many breaks in close proximity, they can lead to double-stranded breaks which stop DNA replication and result in bacterial cell death (Figure 1; D'souza and Harrison, 2003; Wallace, 2014). Indeed, de Moraes et al. found that the DddA delivered by B. cenocepacia suppresses the viability of several other bacterial species, including Pseudomona aeruginosa and Burkholderia thailandensis.

Although DddA causes double-stranded DNA breaks and cell death in most bacterial species, some disease-causing bacteria – including Eschericia coli and Salmonella enterica – are able to resist its detrimental effects. To better understand this observation, de Moraes et al. examined the long-term effects of DddA on these bacteria. They found that rather than excising the uracil that had replaced cytosine, the DNA replication machinery in the infected bacteria converts the uracil into a different nucleotide, thymine. As thymine pairs with adenosine in DNA, C-G pairs throughout the genome get replaced with T-A pairs (Figure 1).

An unanticipated consequence of this exchange was that the bacteria not killed by DddA acquired resistance to the antibiotic rifampicin. Further experiments revealed that other deaminase toxins similar to DddA were also able to introduce mutations in single-stranded DNA, suggesting this may be a widespread mechanism within bacterial populations (de Moraes et al., 2021).

It is generally thought that DNA mutations that arise during natural selection are caused by errors during chromosome replication or by exogenous factors such as chemicals and ionizing stress (Schroeder et al., 2018). Some bacteria rapidly adapt by importing fragments of foreign DNA from the environment and integrating them into their genome. This mechanism has been proposed to increase the genetic variation of populations, which provides a selective advantage to bacteria living in challenging environments or competing with other species (Dubnau and Blokesch, 2019; Mell and Redfield, 2014). The findings of de Moreas et al. suggest a similar mechanism in which the mutations produced by deaminase toxins help to diversify the population, creating new variants that can rapidly adapt to environmental changes.

There are several exciting avenues of research resulting from these findings. First, it is unclear why some bacteria are susceptible to DddA intoxication, whereas others are resistant. Defining these resistance mechanisms could help reveal the biological scenarios in which T6SS helps communities of bacteria adapt to their environment. Second, it will be interesting to determine how DddA toxins alter the composition of bacterial communities: DddA intoxication could eliminate competing species, while the genetic variations induced in resistant species may help enhance the long-term fitness of the community. Lastly, new insights into these topics may increase our understanding of human diseases where pathogenic bacteria come into contact with communities of microbes in the body, such as inflammatory bowel disease and cystic fibrosis, which could ultimately lead to better treatments (Buffie and Pamer, 2013; Spiewak et al., 2019).

References

Article and author information

Author details

  1. Maarten De Jong

    Maarten De Jong is in the Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, United States

    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2278-286X
  2. Neal M Alto

    Neal M Alto Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, United States

    For correspondence
    neal.alto@utsouthwestern.edu
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7602-3853

Publication history

  1. Version of Record published:

Copyright

© 2021, De Jong and Alto

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,763
    views
  • 161
    downloads
  • 2
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Maarten De Jong
  2. Neal M Alto
(2021)
Bacterial Warfare: Toxins, mutations and adaptations
eLife 10:e66676.
https://doi.org/10.7554/eLife.66676
  1. Further reading

Further reading

    1. Cancer Biology
    2. Genetics and Genomics
    Li Min, Fanqin Bu ... Shutian Zhang
    Research Article

    It takes more than 20 years for normal colorectal mucosa to develop into metastatic carcinoma. The long time window provides a golden opportunity for early detection to terminate the malignant progression. Here, we aim to enable liquid biopsy of T1a stage colorectal cancer (CRC) and precancerous advanced adenoma (AA) by profiling circulating small extracellular vesicle (sEV)-derived RNAs. We exhibited a full RNA landscape for the circulating sEVs isolated from 60 participants. A total of 58,333 annotated RNAs were detected from plasma sEVs, among which 1,615 and 888 sEV-RNAs were found differentially expressed in plasma from T1a stage CRC and AA compared to normal controls (NC). Then we further categorized these sEV-RNAs into six modules by a weighted gene coexpression network analysis and constructed a 60-gene t-SNE model consisting of the top 10 RNAs of each module that could well distinguish T1a stage CRC/AA from NC samples. Some sEV-RNAs were also identified as indicators of specific endoscopic and morphological features of different colorectal lesions. The top-ranked biomarkers were further verified by RT-qPCR, proving that these candidate sEV-RNAs successfully identified T1a stage CRC/AA from NC in another cohort of 124 participants. Finally, we adopted different algorithms to improve the performance of RT-qPCR-based models and successfully constructed an optimized classifier with 79.3% specificity and 99.0% sensitivity. In conclusion, circulating sEVs of T1a stage CRC and AA patients have distinct RNA profiles, which successfully enable the detection of both T1a stage CRC and AA via liquid biopsy.

    1. Chromosomes and Gene Expression
    2. Genetics and Genomics
    Erik Toraason, Alina Salagean ... Diana E Libuda
    Research Article

    The preservation of genome integrity during sperm and egg development is vital for reproductive success. During meiosis, the tumor suppressor BRCA1/BRC-1 and structural maintenance of chromosomes 5/6 (SMC-5/6) complex genetically interact to promote high fidelity DNA double strand break (DSB) repair, but the specific DSB repair outcomes these proteins regulate remain unknown. Using genetic and cytological methods to monitor resolution of DSBs with different repair partners in Caenorhabditis elegans, we demonstrate that both BRC-1 and SMC-5 repress intersister crossover recombination events. Sequencing analysis of conversion tracts from homolog-independent DSB repair events further indicates that BRC-1 regulates intersister/intrachromatid noncrossover conversion tract length. Moreover, we find that BRC-1 specifically inhibits error prone repair of DSBs induced at mid-pachytene. Finally, we reveal functional interactions of BRC-1 and SMC-5/6 in regulating repair pathway engagement: BRC-1 is required for localization of recombinase proteins to DSBs in smc-5 mutants and enhances DSB repair defects in smc-5 mutants by repressing theta-mediated end joining (TMEJ). These results are consistent with a model in which some functions of BRC-1 act upstream of SMC-5/6 to promote recombination and inhibit error-prone DSB repair, while SMC-5/6 acts downstream of BRC-1 to regulate the formation or resolution of recombination intermediates. Taken together, our study illuminates the coordinate interplay of BRC-1 and SMC-5/6 to regulate DSB repair outcomes in the germline.